SEC Form 4 · accession 0001192482-15-000019
Spark Therapeutics, Inc. · ONCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Jan 30, 2015
Accepted (ET)
Feb 3, 2015 · 4:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001609351
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $23.00 | Jan 30, 2015 | A | 27,000 | D | — | Jan 30, 2025 | Common Stock | 27,000 | 27,000 | I |
Explanation of responses
- F1This option was granted on January 30, 2015 to A. Lorris Betz, MD, Ph.D., a member of the Board of Trustees and Executive Committee of the Reporting Person and a member of the Board of Directors of the Issuer. The option vests quarterly over four years. Dr. Betz holds this option for the benefit of the Reporting Person.